标题 |
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
卡多尼单抗联合铂类化疗联合或不联合贝伐珠单抗作为持续性、复发性或转移性宫颈癌的一线治疗(COMPASSION-16):一项在中国进行的随机、双盲、安慰剂对照3期试验
|
网址 | |
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
求助人 | |
下载 |